Uzbek
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Muolajalar

03
2020 yil 17 yanvar / Suhbat

Leykemiyani davolashning keng qamrovli sharhi

CAR-T terapiyasi, ximerik antigen retseptorlari T-hujayra immunoterapiyasining qisqartmasi, ilg'or gendir...
Ko'proq o'qish
03
2020 yil 17 yanvar / Intervyu

TIL terapiyasi ochildi: saraton immunoterapiyasining manzarasini o'rganish

TIL terapiyasi o'simtaga infiltratsiya qiluvchi limfotsitlarni (TIL) ajratib olishni o'z ichiga oladi, ular eng aniq ...
Ko'proq o'qish
02
2020 yil 17 yanvar / Suhbat

NK hujayralaridan foydalanish: Saraton terapiyasini chegaralardan tashqarida rivojlantirish

Yoshi oshgani sayin, immunitet hujayralari sonining tabiiy pasayishi tanani viruslarga qarshi himoyasiz qoldiradi ...
Ko'proq o'qish